Trials / Completed
CompletedNCT00521521
Study of Combination Docetaxel and Radiotherapy With or Without Cisplatin to Treat Local Advanced Head and Neck Cancer
A Multicenter, Randomized, Phase II Study of the Combination of Docetaxel (TAXOTERE) and Concomitant Radiotherapy With or Without Cisplatin in Patients With Locally Advanced Head and Neck Cancer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 86 (actual)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy of the concomitant combination of radiotherapy and docetaxel with or without cisplatin in terms of objective response rates (WHO criteria).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | docetaxel and cisplatin | |
| DRUG | docetaxel |
Timeline
- Start date
- 2001-07-01
- Primary completion
- 2006-05-01
- First posted
- 2007-08-28
- Last updated
- 2009-12-07
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00521521. Inclusion in this directory is not an endorsement.